Shire, the FTSE 100 pharmaceutical group, on Tuesday dealt a blow to the UK as a corporate location by announcing it was moving its tax domicile to Ireland.

While the group’s operations will keep its headquarters in the UK, the holding company will be incorporated in Jersey, and pay reduced tax on global earnings in Ireland, where the headline corporate rate is just 12.5 per cent.